dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

European News Homepage

Siemens and ESR present first Digital Experience Hall at ECR Aims to stimulate exchange of thoughts and knowledge about digitization in radiology

Varex Imaging and H+P Advanced Technology to build carbon nanotube company Expect to see products come out in two-to-three years

Varex Imaging expands service offering to Europe, releases new tube and detector line at ECR Provide technical and logistical support for installations

Data sharing for imaging trials low, says ESR research committee at ECR Interest is high but concerns remain

Hitachi unveils new CT and ultrasound solutions at ECR Standard version of SCENARIA VIEW and three new Arietta ultrasound solutions

Age of imaging equipment in Europe is a cause of increasing concern About 20 percent of installed base is over a decade old: COCIR

My one day at ECR: Michael Friebe Dr. Friebe shares his candid insights on the big event

Siemens unveils Artis icono biplane angio system at ECR Enables diagnostics and treatment to take place in same lab, improved 2D and 3D capabilities

ECR Exhibitors A few of the must-visit companies exhibiting at ECR 2019

ECR Product Showcase Some of the products and services on display at ECR 2019

Using PET to reduce toxicity of Hodgkin’s lymphoma treatment

by John W. Mitchell , Senior Correspondent
Using PET scans, researchers at the University of Southampton in the UK, working with colleagues in six other countries, were able to successfully determine which cancer patients were on the road to recovery and no longer required stressful chemotherapy. The results have just been published in the New England Journal of Medicine.

“We have shown that de-escalating therapy by stopping the administration of bleomycin after a good response on the PET scan is safe and effective,” Dr. Peter Johnson, professor of medical Oncology at the Cancer Research UK Centre, Southampton General Hospital, told HCB News. “By reducing the total amount of treatment being given we hope to see fewer long term side effects.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



He said that while the risk of severe toxicity from Bleomycin is “generally low”, for a small number of patients the chemotherapy drug can be life-changing or even fatal. The adverse symptoms for a minority patients include nausea and vomiting, lung complications including fibrosis, anaphylactic shock, and in some cases, heart attack and stroke.

Johnson said that he expects to see more early use of PET scanning to guide Hodgkin’s lymphoma treatment.

“People with a clear scan after two cycles should be able to stop receiving bleomycin and in many cases will not need radiotherapy after their chemotherapy,” said Johnson. He added that for patients with a persistently abnormal scan there is the option of escalated treatment which was able to produce durable remissions in two thirds of patients.

The study was conducted in the U.K., Italy, Norway, Sweden, Denmark, Australia and New Zealand. He said his colleagues have been “very positive” about the results.

“The underlying reason to do this is that although cure rates are high in this illness, we would like to reduce the long-term side effects by tailoring the intensity of treatment to patients’ needs,” Johnson added.

According to the American Cancer Society (ACS), Hodgkin’s Disease is a type of cancer that starts in the lymphocytes of the white blood cells and grows out of control. The ACS estimates that 8,500 new cases will be diagnosed in the U.S in 2016, with 1,120 deaths. The death rate from the disease has been steadily dropping since the 1970’s.

“I think it is important to emphasize that for people under the age of 60, the outlook for Hodgkin’s lymphoma is very good,” Johnson said. “A lot fewer people died from the lymphoma than from other causes, emphasizing the need to minimize toxicity while maximizing cures.”

European News Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED